|
|
Article: Mach One Corporation Expedites Co-Development Plans with PanTheryx for Introduction of Novel Product for Treatment of Pediatric Diarrhea.
- Article from:
- Business Wire
- Article date:
- November 12, 2009
CopyrightCOPYRIGHT 2009 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Building Foundation as a Global Supplier for Immunotherapeutic Solutions
BELGIUM, Wis. -- Mach One Corporation (OTCBB: MNCN), a rapidly growing, innovative, global wellness solutions company, announced today that it has completed the first tranche of its investment in PanTheryx, Inc., as stipulated in a recent Letter of Understanding signed in August 2009. This action expedites development and introduction plans for an orally administered antibody therapeutic for treatment of pediatric diarrhea. The co-developed pediatric diarrhea product will initially be targeted for commercial introduction in India, where PanTheryx maintains a sales force and contract sales ...
Related newspaper, magazine, and journal articles:
|
|
Article: Mach One Inks Supply Pact with PanTheryx
Wireless News;
August 25, 2009 ;
422 words
... ... PanTheryx Type: News Mach, a wellness solutions ... of a broad- spectrum pediatric diarrhea product. Through a ... excited to team-up with Mach One, to further our ... term health benefits. Pediatric diarrhea is a serious and widespread ...
|
|